Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Taxes (2016 - 2025)

Sanofi's Current Taxes history spans 11 years, with the latest figure at $874.2 million for Q4 2025.

  • For Q4 2025, Current Taxes rose 17.37% year-over-year to $874.2 million; the TTM value through Dec 2025 reached $874.2 million, up 17.37%, while the annual FY2025 figure was $848.5 million, 12.47% up from the prior year.
  • Current Taxes for Q4 2025 was $874.2 million at Sanofi, up from $744.8 million in the prior quarter.
  • Across five years, Current Taxes topped out at $874.2 million in Q4 2025 and bottomed at $353.5 million in Q4 2021.
  • The 5-year median for Current Taxes is $642.3 million (2023), against an average of $640.1 million.
  • The largest annual shift saw Current Taxes tumbled 50.91% in 2021 before it surged 65.67% in 2022.
  • A 5-year view of Current Taxes shows it stood at $353.5 million in 2021, then soared by 65.67% to $585.6 million in 2022, then increased by 9.68% to $642.3 million in 2023, then increased by 15.95% to $744.8 million in 2024, then increased by 17.37% to $874.2 million in 2025.
  • Per Business Quant, the three most recent readings for SNY's Current Taxes are $874.2 million (Q4 2025), $744.8 million (Q4 2024), and $642.3 million (Q4 2023).